News today in the NY Times that the drug companies' industry group PhRMA is going to be running $150 million in pro-health care reform ads should be setting off huge alarms for everyone.The unusually large scale of the industry’s commitment to the cause helps explain some of a contentious back-and-forth playing out in recent days between the odd-couple allies over a deal that the White House
0 Comments